Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-09-24FDA Approved: FOSRENOL — Original Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved Fosrenol (lanthanum carbonate) through Takeda's original NDA to treat hyperphosphatemia in adults with chronic kidney disea…
-
FDA approval · 2014-09-24FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2014-09-24FDA Approved: VELPHORO — Supplemental Application (Fresenius Medical Care Renal Therapies Group, LLC)
The FDA approved a supplemental application for Velphoro (sucroferric oxyhydroxide) from Fresenius Medical Care Renal Therapies Group, LLC.
-
CLINICAL_TRIALS trial_result · 2014-09-23Clinical Trial Update: A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With Hyperphosphatemia [Phase 3]
Phase 3 study of MCI-196 in chronic kidney disease patients on dialysis with hyperphosphatemia completed; results posted in 2014.
-
CLINICAL_TRIALS safety_alert · 2014-09-22Clinical Trial Update: Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
A clinical trial update reports the risk of Nephrogenic Systemic Fibrosis in patients with moderate renal insufficiency following administra…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2014-09-22Clinical Trial Update: Effects of High-intensity Interval Training in Patients in Hemodialysis [NA]
A clinical trial update on the effects of high-intensity interval training in patients undergoing hemodialysis. The current status is unknow…
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Safety and Efficacy of BMMNC in Patients With Chronic Renal Failure [Phase 1, Phase 2]
A clinical trial evaluating the safety and efficacy of bone marrow mononuclear cells (BMMNC) in patients with chronic kidney disease, conduc…
-
CLINICAL_TRIALS research · 2014-09-16Clinical Trial Update: Efficacy Trial of N-Acetylcysteine and Sodium Bicarbonate for the Prevention of Contrast-Induced Acute Kidney Injury [Phase 3]
A Phase 3 trial is evaluating whether N-acetylcysteine and sodium bicarbonate can prevent contrast-induced acute kidney injury in patients w…
-
CLINICAL_TRIALS trial_result · 2014-09-15Clinical Trial Update: Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)
A completed clinical trial evaluated Zemplar capsules (paricalcitol) for the treatment of secondary hyperparathyroidism in chronic kidney di…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Usefulness of Neutrophil Gelatinase-associated Lipocalin(NGAL) to Confirm Acute Kidney Function Decrease of the Patients Who Had Non-cardiac Surgery
This trial update evaluates whether neutrophil gelatinase-associated lipocalin (NGAL) can confirm acute kidney function decline in patients …
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: Impact of Vitamin B12 Replacement on Epogen Dosing and Improvement of Quality of Life in Hemodialysis Patients [NA]
Completed clinical trial evaluated whether Vitamin B12 supplementation in hemodialysis patients reduces Epogen (epoetin alfa) dosing and imp…
-
CLINICAL_TRIALS trial_result · 2014-09-08Clinical Trial Update: The Effect of Neutral Peritoneal Dialysis (PD) Solution With Minimal Glucose-Degradation-Product (GDP) on Fluid Status and Body Composition [Phase 4]
Phase 4 clinical trial assessing a neutral peritoneal dialysis solution with minimal glucose-degradation-products on fluid status and body c…
-
FDA approval · 2014-09-05FDA Approved: FERRIC CITRATE — Original Application (Mylan Pharmaceuticals Inc.)
FDA approved Ferric Citrate from Mylan as an original application to treat hyperphosphatemia in adults with chronic kidney disease on dialys…
-
CLINICAL_TRIALS trial_result · 2014-09-01Clinical Trial Update: Urologic-nephrological Care of Chronic Kidney Disease in Saxony-Anhalt/Magdeburg.
This clinical trial update notes the completion of the urologic-nephrological care study for chronic kidney disease conducted in Saxony-Anha…
-
CLINICAL_TRIALS trial_result · 2014-08-28Clinical Trial Update: Redox State in the Course of Chronic Renal Insufficiency and Hemodialysis: Implications in Morbimortality [NA]
A completed clinical trial evaluating how redox state evolves in chronic kidney disease and during hemodialysis and its implications for mor…
-
CLINICAL_TRIALS trial_result · 2014-08-26Clinical Trial Update: An Open-label, Non-randomized, Parallel Group Study in Subjects With Mild, Moderate, Severe, or No Renal Impairment [Phase 4]
An open-label, non-randomized Phase 4 trial in subjects with varying degrees of renal impairment (mild, moderate, severe, or no impairment) …
-
FDA approval · 2014-08-07FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care North America)
The FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care North America, comprising dextrose …
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) [Phase 4]
Phase 4 trial comparing paricalcitol to calcitriol for efficacy and safety in stage 3/4 chronic kidney disease with secondary hyperparathyro…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients [Phase 4]
Phase 4 long-term evaluation comparing sevelamer hydrochloride with a calcium-based phosphate binder in hyperphosphatemia among hemodialysis…
-
CLINICAL_TRIALS trial_result · 2014-08-05Clinical Trial Update: ENdothelial DysfUnction in Renal Disease and Exercise Training [NA]
This update reports a completed clinical trial investigating endothelial dysfunction in chronic kidney disease and the effects of exercise t…
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Telemonitoring to Improve Outcomes of Patients With Chronic Kidney Disease (CKD) [Phase 3]
Phase 3 clinical trial evaluating telemonitoring to improve outcomes in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-08-01Clinical Trial Update: Residual Renal Function Preservation in Peritoneal Dialysis Patients [NA]
This document is a clinical trial update focused on preserving residual renal function in patients undergoing peritoneal dialysis, with the …
-
CLINICAL_TRIALS research · 2014-08-01Clinical Trial Update: The Cost Effectiveness and Evaluation of Disease Management of Chronic Kidney Disease and High Risk Population [NA]
This is a clinical trial update evaluating the cost-effectiveness and disease management for chronic kidney disease in high-risk populations…
-
CLINICAL_TRIALS trial_result · 2014-07-31Clinical Trial Update: Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney Disease [Phase 3]
A phase 3 study evaluating sevelamer for secondary hyperparathyroidism in chronic kidney disease has completed, with results posted in 2014.
-
FDA approval · 2014-07-30FDA Approved: HUMATROPE — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Humatrope (somatropin) from Eli Lilly and Company.